从天生的力量到智能设计:基于NK细胞的癌症免疫疗法的演变
Israth Jahan Tuhin1, Hong Jia Zhu2, Masuma Akter Monty3
1Research and Development Department, Shanghai Unicar Therapy Bio-Medicine Technology Co., Ltd., 2699, Panjing Road, , Shanghai, China.
Critical reviews in oncology/hematology
|October 1, 2025
概括
自然杀手 (NK) 细胞提供强大的癌症免疫疗法,但在固体瘤中面临挑战. 基因工程和组合策略正在提高NK细胞的持久性和有效性,以改善癌症治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 自然杀手 (NK) 细胞是有前途的免疫疗法平台,因为它们具有固有的细胞毒性和安全性,可用于现成治疗.
- NK细胞的临床疗效,特别是在固体瘤中,受到体内持久性差,瘤透和免疫抑制瘤微环境 (TME) 的阻碍.
研究的目的:
- 审查基因工程NK细胞的最新进展,以克服癌症免疫疗法的局限性.
- 探索结合策略和新平台,以增强NK细胞癌症疗法.
主要方法:
- 讨论 NK 细胞的仿制抗原受体 (CAR) 的优化.
- 突出了免疫检查点抵抗,代谢重编程和细胞因子支持的整合.
- 检查组合疗法 (例如单克隆抗体,瘤病毒) 和先进的输送系统 (例如纳米粒子,外体).
主要成果:
- 基因工程策略显示出改善NK细胞生存,透和抗瘤功能的潜力.
- 组合疗法和新型平台提供协同效应,以增强NK细胞抗瘤活性.
- 通过精密工程和免疫调节来解决NK细胞的局限性,对于临床成功至关重要.
结论:
- 基因工程NK细胞与协同策略相结合,正在向前线癌症治疗迈进.
- 本综述为开发具有显著转化潜力的下一代NK细胞疗法提供了路线图.
- 基于NK细胞的免疫疗法正在发展,以克服当前治疗固体瘤的临床挑战.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
T Cell Activation and Clonal Selection
14.8K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.8K
Cells of the Innate Immune Response
8.7K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.7K
Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


